SCHEMBL31293622

SCHEMBL31293622

Cc1nc2cc(-c3ccccc3O)nnc2cc1N1CC2(CN(C(=O)OC(C)(C)C)C2)C1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 4/20 0.53
▸ SMARCA4 P51532 4/20 0.53
▸ PBRM1 Q86U86 4/20 0.53
▸ CYP11B2 P19099 1/20 0.40
▸ PARP1 P09874 3/20 0.39
▸ PIM1 P11309 4/20 0.36
▸ PIM2 Q9P1W9 4/20 0.36
▸ PDK2 Q15119 1/20 0.36
▸ KRAS P01116 1/20 0.36
▸ SCD5 Q86SK9 1/20 0.35
▸ EGLN2 Q96KS0 1/20 0.35
▸ NR1I2 O75469 2/20 0.35
▸ OXTR P30559 1/20 0.34
▸ AVPR1A P37288 1/20 0.34
▸ ACACB O00763 2/20 0.34
▸ GPR119 Q8TDV5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30632526 0.82 SMARCA2 (0.50) SMARCA2SMARCA4PBRM1CYP11B2PARP1
SCHEMBL26685126 0.82 SMARCA2 (0.50) SMARCA2SMARCA4PBRM1CYP11B2PARP1
SCHEMBL31293862 0.82 OXTR (0.40) CYP11B2PARP1KRASEGLN2OXTR
SCHEMBL30666247 0.80 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1CYP11B2PARP1
SCHEMBL26683498 0.80 SMARCA2 (0.52) SMARCA2SMARCA4PBRM1CYP11B2PARP1
SCHEMBL31293952 0.80 PBRM1 (0.41) SMARCA2SMARCA4PBRM1NR1I2
SCHEMBL29619441 0.79 SMARCA2 (0.53) SMARCA2SMARCA4PBRM1CYP11B2PARP1
SCHEMBL30632451 0.76 SMARCA2 (0.43) SMARCA2SMARCA4PBRM1CYP11B2PARP1
SCHEMBL26685144 0.76 SMARCA2 (0.43) SMARCA2SMARCA4PBRM1CYP11B2PARP1
SCHEMBL30666283 0.76 SMARCA2 (0.50) SMARCA2SMARCA4PBRM1CYP11B2PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709726-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2026-03-18 — — EP disclosed
WO-2024233717-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2024-11-14 — — WO disclosed
Send feedback